Edition:
India

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

2.85USD
20 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.85
Open
$2.85
Day's High
$2.88
Day's Low
$2.77
Volume
119,220
Avg. Vol
233,113
52-wk High
$7.35
52-wk Low
$1.55

About

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its... (more)

Overall

Beta: --
Market Cap(Mil.): $96.98
Shares Outstanding(Mil.): 43.26
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates